MiRus's $1.5B: A Medtech Megaround in an AI-Dominated Market
MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.
Healthtech venture capital spans digital health platforms, care delivery innovation, diagnostics, and AI-enabled clinical workflows. Our healthtech coverage tracks the funding rounds and fund strategies defining the next generation of healthcare technology.
Browse healthtech venture capital articles below.
MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.
Nourish closed $100M Series C in NYC — the country's largest dietitian-led metabolic health clinic scales virtual care with real clinical outcomes.
Century Health raised $5M seed in NYC — CHARM model hits 97% accuracy on clinical data abstraction for life sciences R&D.
Anagram Therapeutics raised $250M in May 2026, one of the largest biotech rounds of the period, proving life-sciences capital is alive alongside AI.
NYC digital health raised $2.4B in H1 2025 (+10% YoY). Life sciences took 27% of NYC venture funding. Here's where the money went and who's writing checks.
Parallel's Paris round highlights Europe's growing confidence in vertical AI agents for regulated industries like healthcare.